TNF and psoriasis: In line, new treatment options for PSO, such as systemic therapy, acting as inhibitors for certain pro-inflammatory cytokines [e.g., secukinumab as interleukin(IL)-17 inhibitor], or biologics, acting as TNF-α inhibitors, are effective treatment options for moderate-to-severe psoriasis forms (35).